Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734887 · ClinicalTrials.gov registry record · NA
Social Engagement Strategies to Improve Medication Adherence
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03734887 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 43 participants.
The verdict
NCT03734887, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
In this pilot study, investigators, in partnership with Resource Centers for Minority Aging Research (RCMAR) mentorship team and the MyMeds program, will enroll patients from MyMeds with diabetes, atherosclerotic cardiovascular disease, or congestive heart failure with poor medication adherence (medication adherence percentage\<80% for statin or antihypertensive therapy) who report having a least one loved one or friend (e.g., spouse) whom they consider to be invested in their health, and with whom they would be willing to share focused medical information about medication adherence in the form of text messages. Participants will be randomized into either a private feedback arm or social network arm. In the private feedback arm, participants will only receive private consultations from a pharmacist regarding their medication adherence rates. In the social network arm, participants and their chosen loved one or friend will receive bi-weekly feedback text messages regarding the participant's medication adherence. Investigators will evaluate the effects of this social network intervention on medication adherence and examine the program's acceptability among study participants. This proposal is innovative because it leverages social networks-largely unused in medical care-for health improvement.
Interventions
- BEHAVIORAL Social Network Feedback
- BEHAVIORAL Private Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03734887
The ClinicalTrials.gov registry entry for NCT03734887 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Social Network Feedback is the first listed.
NCT03734887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03734887 about?
NCT03734887 is a clinical study titled "Social Engagement Strategies to Improve Medication Adherence". In this pilot study, investigators, in partnership with Resource Centers for Minority Aging Research (RCMAR) mentorship team and the MyMeds program, will enroll patients from MyMeds with diabetes, atherosclerotic cardiovascular disease, or congestive heart failure with poor medication adherence (med...
What is the current status of trial NCT03734887?
This trial is currently terminated. It is a NA study. The enrollment target is 43 participants. The study started on 2019-10-31. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT03734887?
The interventions under investigation include: Social Network Feedback (BEHAVIORAL), Private Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03734887?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.